SOPHiA GENETICS Announces It Joins the European Liquid Biopsy Society at ECP 2024
The Society brings together over 87 academic and industry leaders in liquid biopsy.
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024
The companies share how their collaboration enables clinical trial enrollment for a novel cancer therapy for oncogene amplified cancers in development by Boundless Bio.
SOPHiA GENETICS Unveils New Generation of the SOPHiA DDM™ Platform at Morgan Stanley Healthcare Conference 2024
New generation of SOPHiA DDM™ integrates latest advancements in data processing and technology to deliver elevated experience and capabilities to customers.
SOPHiA DDM™ Platform Certified Under IVDR
Regulatory milestone validates the SOPHiA DDM™ Platform as diagnostic tool in select markets.
Enhancing variant interpretation: Obtaining answers from a vast universe of data
Pinpointing pathogenic mutations from large, complex datasets can be difficult, time-consuming, and somewhat overwhelming. So, how can you streamline your genomic analysis, to make it quicker, easier, and more efficient? In this webinar you will learn how Alamut™...
SOPHiA GENETICS Reports Second Quarter 2024 Results
Strength in U.S. Growth Offset by Challenges in BioPharma and EMEA; Strong Cost Management Buffers Loss
SOPHiA GENETICS Announces L’hôpital Universitaire Avicenne is Live on SOPHiA DDM™
OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™
Webinar Series – Episode 2: Decoding Complexity: Advanced Techniques for Detecting Low Allele Frequency Variants
Decoding Complexity - Overcoming Real-World Challenges in Variant Analysis Join us for the second episode of our webinar series, where we delve deeper into the complexities of variant analysis. Our esteemed bioinformatics experts will share practical solutions to...
Unlocking precision medicine through high-throughput sequencing in pharmacogenetics: RNPGx experience
Join us for an enlightening webinar on the evolution of pharmacogenetics, from its historical roots to the impact of groundbreaking innovations and the establishment of specialist foundations. We will explore the introduction of crucial guidelines and annotations...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™
Society of Genetics of Brazil Congress
The SBG Congress in Brazil, organized by the Brazilian Society of Genetics is a prestigious event that gathers leading scientists and researchers in the field of genetics. This annual congress provides a platform for the presentation of cutting-edge research,...
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024
BOSTON, United States and ROLLE, Switzerland, July 23, 2024 — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal year 2024...
